Christopher W Rowe

9PUBLICATIONS
3CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthModels of care and place of birthNeurosciences not elsewhere classifiedAdolescent healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 29, 2023
Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy.

Christopher W Rowe, Patrick Rosee, Angeline Sathiakumar

|Nov 09, 2022
Adoption of a pregnancy-specific intravenous insulin protocol (Pregnancy-IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospital.

Christopher W Rowe, Vivian Qiao, Soundarya Ramesh

|Apr 16, 2022
Re: Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes - An updated guideline from the Joint British Diabetes Society for Inpatient Care.

Christopher W Rowe, Katie Wynne

|Dec 05, 2020
Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes.

Christopher W Rowe, Brendan Watkins, Karina Brown

|Nov 29, 2019
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis.

Christopher W Rowe, Sam Faulkner, Jonathan W Paul

|Sep 11, 2019
Young children, adolescent girls and women with type 1 diabetes are more overweight and obese than reference populations, and this is associated with increased cardiovascular risk factors.

A L Marlow, C W Rowe, D Anderson

Pageof 2

Frequent Collaborators

1 joint publications

A L Marlow

1 joint publications

K Wynne

1 joint publications

C E Smart